During the past decade, University of Arizona Health Sciences Center conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 26 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 6 clinical trials were completed. i.e. 120% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Arizona Health Sciences Center" #1 sponsor was "Children's Oncology Group" with 11 trials, followed by "National Cancer Institute (NCI)" with 10 trials sponsored, "National Institute of Allergy and Infectious Diseases (NIAID)" with 6 trials sponsored, "Eli Lilly and Company" with 4 trials sponsored and "Glaxo Wellcome" with 4 trials sponsored. Other sponsors include 38 different institutions and companies that sponsored additional 40 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Arizona Health Sciences Center" #1 collaborator was "National Cancer Institute (NCI)" with 20 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 4 trials as a collaborator, "Pfizer" with 2 trials as a collaborator, "Alzheimer's Disease Cooperative Study (ADCS)" with 1 trials as a collaborator and "Brigham and Women's Hospital" with 1 trials as a collaborator. Other collaborators include 14 different institutions and companies that were collaborators in the rest 24 trials.

According to Clinical.Site data, the most researched conditions in "University of Arizona Health Sciences Center" are "HIV Infections" (11 trials), "Alzheimer's Disease" (5 trials), "Epilepsy" (3 trials), "Healthy, no Evidence of Disease" (3 trials) and "Untreated Adult Acute Lymphoblastic Leukemia" (3 trials). Many other conditions were trialed in "University of Arizona Health Sciences Center" in a lesser frequency.

Most popular intervention types in "University of Arizona Health Sciences Center" are "Drug" (60 trials), "Other" (21 trials), "Procedure" (14 trials), "Biological" (13 trials) and "Radiation" (8 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "laboratory biomarker analysis" (9 trials), "Zidovudine" (5 trials), "placebo" (5 trials) and "Clarithromycin" (3 trials). Other intervention names were less common.

The vast majority of trials in "University of Arizona Health Sciences Center" are 74 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "University of Arizona Health Sciences Center". undefined are not yet recruiting, 4 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 59 completed trials in University of Arizona Health Sciences Center, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in University of Arizona Health Sciences Center, 8 "Phase 1" clinical trials were conducted, 25 "Phase 2" clinical trials and 27 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 15 trials that are defined as “Not Applicable".